The are now back to just 'BOS'. In regards to what our shares are worth, it is anyones guess. As Espinsight highlighted, too many factors here. And I dare say, whoever is in charge of the company hasn't a clue either.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025